National Healthcare Stock Z Score

NHC Stock

USD 105.75 0.42 0.40%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out National HealthCare Piotroski F Score and National HealthCare Valuation analysis.

For information on how to trade National Stock refer to our How to Trade National Stock guide.

At present, National HealthCare's Capital Lease Obligations is projected to increase significantly based on the last few years of reporting. The current year's Net Invested Capital is expected to grow to about 921 M, whereas Capital Surpluse is forecasted to decline to about 234.7 M. At present, National HealthCare's Operating Income is projected to decrease significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 54.5 M, whereas Depreciation And Amortization is forecasted to decline to about 25.8 M.

National HealthCare Company Z Score Analysis

National HealthCare's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

National Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for National HealthCare is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Z Score. Since National HealthCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National HealthCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National HealthCare's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Retained Earnings	Short Term Investments	Common Stock	Good Will	Property Plant Equipment	Current Deferred Revenue	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Accumulated Depreciation	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.79	-0.12	0.87	0.91	0.83	0.78	-0.16	0.03	0.73	0.78	0.82	0.3	0.89	-0.21	0.55	0.63	-0.18	0.62	-0.37	-0.17	-0.61	0.53	0.2	-0.29	0.07
Total Stockholder Equity	0.79		-0.35	0.71	0.85	0.56	0.73	-0.03	0.1	0.92	0.65	0.82	0.63	0.79	0.0	0.63	0.67	-0.36	0.65	-0.51	-0.32	-0.66	0.5	0.55	-0.03	0.41
Net Debt	-0.12	-0.35		0.08	-0.31	0.28	-0.47	-0.41	-0.44	-0.08	-0.12	-0.13	0.07	-0.28	0.26	0.22	0.2	0.19	0.26	-0.15	0.25	-0.17	0.15	0.08	-0.17	-0.11
Accounts Payable	0.87	0.71	0.08		0.8	0.88	0.51	-0.47	-0.09	0.75	0.74	0.8	0.3	0.83	-0.12	0.76	0.65	0.03	0.76	-0.32	-0.02	-0.68	0.55	0.22	-0.21	0.12
Net Receivables	0.91	0.85	-0.31	0.8		0.63	0.76	-0.08	0.16	0.76	0.73	0.91	0.35	0.94	-0.23	0.54	0.61	-0.08	0.63	-0.36	-0.1	-0.57	0.32	0.24	-0.17	0.22
Total Liab	0.83	0.56	0.28	0.88	0.63		0.46	-0.46	-0.23	0.65	0.67	0.64	0.19	0.66	0.06	0.66	0.63	-0.11	0.71	-0.21	-0.07	-0.69	0.71	0.11	-0.33	-0.01
Total Current Assets	0.78	0.73	-0.47	0.51	0.76	0.46		0.43	0.31	0.52	0.64	0.6	0.19	0.7	-0.3	0.18	0.32	-0.3	0.23	-0.2	-0.27	-0.28	0.43	0.13	-0.03	0.07
Short Term Debt	-0.16	-0.03	-0.41	-0.47	-0.08	-0.46	0.43		0.45	-0.27	-0.1	-0.25	-0.15	-0.15	-0.21	-0.54	-0.41	-0.18	-0.56	0.17	-0.16	0.48	-0.27	-0.13	0.09	-0.11
Intangible Assets	0.03	0.1	-0.44	-0.09	0.16	-0.23	0.31	0.45		-0.25	0.35	-0.01	-0.36	0.36	-0.63	-0.46	-0.53	0.54	-0.42	0.39	0.61	0.53	-0.46	-0.31	0.25	-0.21
Retained Earnings	0.73	0.92	-0.08	0.75	0.76	0.65	0.52	-0.27	-0.25		0.54	0.84	0.76	0.65	0.24	0.83	0.88	-0.46	0.86	-0.64	-0.43	-0.88	0.65	0.68	-0.09	0.51
Short Term Investments	0.78	0.65	-0.12	0.74	0.73	0.67	0.64	-0.1	0.35	0.54		0.72	0.07	0.86	-0.24	0.42	0.37	0.12	0.48	-0.02	0.11	-0.37	0.36	0.01	-0.05	0.07
Common Stock	0.82	0.82	-0.13	0.8	0.91	0.64	0.6	-0.25	-0.01	0.84	0.72		0.54	0.85	0.1	0.7	0.8	-0.14	0.84	-0.42	-0.12	-0.68	0.44	0.46	0.09	0.54
Good Will	0.3	0.63	0.07	0.3	0.35	0.19	0.19	-0.15	-0.36	0.76	0.07	0.54		0.17	0.43	0.61	0.8	-0.59	0.64	-0.88	-0.47	-0.65	0.44	0.98	0.18	0.72
Property Plant Equipment	0.89	0.79	-0.28	0.83	0.94	0.66	0.7	-0.15	0.36	0.65	0.86	0.85	0.17		-0.34	0.47	0.45	0.14	0.55	-0.17	0.13	-0.44	0.25	0.09	-0.11	0.11
Current Deferred Revenue	-0.21	0.0	0.26	-0.12	-0.23	0.06	-0.3	-0.21	-0.63	0.24	-0.24	0.1	0.43	-0.34		0.37	0.44	-0.54	0.37	-0.11	-0.47	-0.29	0.3	0.44	0.21	0.68
Deferred Long Term Liab	0.55	0.63	0.22	0.76	0.54	0.66	0.18	-0.54	-0.46	0.83	0.42	0.7	0.61	0.47	0.37		0.8	-0.27	0.88	-0.49	-0.32	-0.82	0.58	0.52	-0.13	0.45
Net Tangible Assets	0.63	0.67	0.2	0.65	0.61	0.63	0.32	-0.41	-0.53	0.88	0.37	0.8	0.8	0.45	0.44	0.8		-0.49	0.93	-0.73	-0.44	-0.89	0.67	0.73	-0.03	0.6
Long Term Debt Total	-0.18	-0.36	0.19	0.03	-0.08	-0.11	-0.3	-0.18	0.54	-0.46	0.12	-0.14	-0.59	0.14	-0.54	-0.27	-0.49		-0.21	0.51	0.93	0.42	-0.52	-0.54	0.09	-0.4
Capital Surpluse	0.62	0.65	0.26	0.76	0.63	0.71	0.23	-0.56	-0.42	0.86	0.48	0.84	0.64	0.55	0.37	0.88	0.93	-0.21		-0.53	-0.18	-0.91	0.63	0.57	-0.02	0.53
Long Term Investments	-0.37	-0.51	-0.15	-0.32	-0.36	-0.21	-0.2	0.17	0.39	-0.64	-0.02	-0.42	-0.88	-0.17	-0.11	-0.49	-0.73	0.51	-0.53		0.43	0.63	-0.37	-0.84	0.12	-0.37
Short Long Term Debt	-0.17	-0.32	0.25	-0.02	-0.1	-0.07	-0.27	-0.16	0.61	-0.43	0.11	-0.12	-0.47	0.13	-0.47	-0.32	-0.44	0.93	-0.18	0.43		0.39	-0.45	-0.41	0.18	-0.31
Accumulated Depreciation	-0.61	-0.66	-0.17	-0.68	-0.57	-0.69	-0.28	0.48	0.53	-0.88	-0.37	-0.68	-0.65	-0.44	-0.29	-0.82	-0.89	0.42	-0.91	0.63	0.39		-0.75	-0.56	0.25	-0.33
Cash And Equivalents	0.53	0.5	0.15	0.55	0.32	0.71	0.43	-0.27	-0.46	0.65	0.36	0.44	0.44	0.25	0.3	0.58	0.67	-0.52	0.63	-0.37	-0.45	-0.75		0.41	0.02	0.22
Net Invested Capital	0.2	0.55	0.08	0.22	0.24	0.11	0.13	-0.13	-0.31	0.68	0.01	0.46	0.98	0.09	0.44	0.52	0.73	-0.54	0.57	-0.84	-0.41	-0.56	0.41		0.29	0.74
Net Working Capital	-0.29	-0.03	-0.17	-0.21	-0.17	-0.33	-0.03	0.09	0.25	-0.09	-0.05	0.09	0.18	-0.11	0.21	-0.13	-0.03	0.09	-0.02	0.12	0.18	0.25	0.02	0.29		0.62
Capital Stock	0.07	0.41	-0.11	0.12	0.22	-0.01	0.07	-0.11	-0.21	0.51	0.07	0.54	0.72	0.11	0.68	0.45	0.6	-0.4	0.53	-0.37	-0.31	-0.33	0.22	0.74	0.62

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict National HealthCare

Based on the company's disclosures, National HealthCare has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.

National HealthCare Current Valuation Drivers

We derive many important indicators used in calculating different scores of National HealthCare from analyzing National HealthCare's financial statements. These drivers represent accounts that assess National HealthCare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National HealthCare's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	1.3B	1.0B	1.0B	1.4B	1.3B	1.3B
Enterprise Value	1.3B	1.1B	1.1B	1.4B	1.2B	1.3B

National HealthCare ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National HealthCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National HealthCare's managers, analysts, and investors.

Environmental

Governance

Social

National Fundamentals

	Return On Equity	0.0889
	Return On Asset	0.0275
	Profit Margin	0.07 %
	Operating Margin	0.05 %
	Current Valuation	1.5 B
	Shares Outstanding	15.4 M
	Shares Owned By Insiders	19.72 %
	Shares Owned By Institutions	55.53 %
	Number Of Shares Shorted	509.79 K
	Price To Earning	22.85 X
	Price To Book	1.51 X
	Price To Sales	1.21 X
	Revenue	1.12 B
	Gross Profit	388.11 M
	EBITDA	87.99 M
	Net Income	66.8 M
	Cash And Equivalents	58.67 M
	Cash Per Share	14.19 X
	Total Debt	93.39 M
	Debt To Equity	0.17 %
	Current Ratio	1.76 X
	Book Value Per Share	60.05 X
	Cash Flow From Operations	111.22 M
	Short Ratio	11.94 X
	Earnings Per Share	5.27 X
	Target Price	6.15
	Number Of Employees	13.12 K
	Beta	0.38
	Market Capitalization	1.63 B
	Total Asset	1.31 B
	Retained Earnings	687.6 M
	Working Capital	191.76 M
	Current Asset	164.61 M
	Current Liabilities	114.08 M
	Annual Yield	0.02 %
	Five Year Return	2.89 %
	Net Asset	1.31 B
	Last Dividend Paid	2.36

About National HealthCare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze National HealthCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National HealthCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
BAC	Bank of America
GM	General Motors

When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National HealthCare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out National HealthCare Piotroski F Score and National HealthCare Valuation analysis.

For information on how to trade National Stock refer to our How to Trade National Stock guide.

Note that the National HealthCare information on this page should be used as a complementary analysis to other National HealthCare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for National Stock analysis

When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.

	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Global Correlations Find global opportunities by holding instruments from different markets

Is National HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.224

Dividend Share

2.36

Earnings Share

5.27

Revenue Per Share

75.942

Quarterly Revenue Growth

0.102

The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Healthcare Stock Z Score

National HealthCare Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

National Z Score Driver Correlations

National HealthCare Current Valuation Drivers

National HealthCare ESG Sustainability

National Fundamentals

About National HealthCare Fundamental Analysis

Also Currently Popular

Complementary Tools for National Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY